Books > Medicine > Clinical & internal medicine > Haematology
|
Buy Now
Handbook of Chronic Myeloid Leukemia (Paperback)
Loot Price: R1,640
Discovery Miles 16 400
|
|
Handbook of Chronic Myeloid Leukemia (Paperback)
Expected to ship within 10 - 15 working days
|
This concise, clinically focused pocket handbook assembles and
synthesizes the latest developments and trends in the diagnosis and
treatment of CML and provides an authoritative and convenient
summary of the latest progress in TKI trials, the molecular
monitoring of CML responses, and the development of new therapies
to overcome resistance and improve patient care. Chronic myeloid
leukemia (CML) is a rare type of leukemia (1-2 per 100,000 people)
but is the most common chronic myeloproliferative neoplasm. CML
remains a key model for the improved understanding of the
pathophysiology of a malignancy at a molecular level; CML was the
first cancer to be associated with a recurring chromosome
abnormality, which generates the Philadelphia (Ph) chromosome and
its associated fusion gene BCR-ABL1. The clinical outcome for
patients with CML has changed dramatically in the past 15 years and
this has been due to the development of tyrosine kinase inhibitors
(TKIs), compounds that inhibit the activity of the oncogenic
BCR-ABL1 protein. A number of first-, second- and third-generation
TKIs are now available for the treatment of CML, although a number
of treatment challenges remain, not least the development of
treatment-resistant CML. Parallel to the development of specific
drugs for treating CML, major advances have been made in the field
of disease monitoring and standardization of response criteria.
General
Is the information for this product incomplete, wrong or inappropriate?
Let us know about it.
Does this product have an incorrect or missing image?
Send us a new image.
Is this product missing categories?
Add more categories.
Review This Product
No reviews yet - be the first to create one!
|
|
Email address subscribed successfully.
A activation email has been sent to you.
Please click the link in that email to activate your subscription.